Alembic Pharmaceuticals inaugurates anti-cancer manufacturing facility at Halol

15 Jul 2017 Evaluate

Alembic Pharmaceuticals has inaugurated its state of the art anti-cancer manufacturing facility located at Panelav, Halol in state of Gujarat. The plant has been set-up entailing an investment of Rs 300 crore and has an initial manufacturing capacity of 60 million tablets / capsules and approximate 20 million vials of liquid injectable and lyophilized concentrates.

With this oncology manufacturing facility being inaugurated, the company will make an entry in the growing global oncology segment and will commence exporting, oncology products to US, Middle East, North Africa, Australia and South Africa.

This manufacturing facility is designed with Containment Control Automated Standards & major equipment were imported like BOSCH from Germany, GEA from Belgium, Alexanderwerk from UK, ICOS from Italy, Tofflon from China.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.


Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×